Yi Lin, MD, PhD, hematologist and oncologist, Mayo Clinic, discusses the efficacy of ciltacabtagene autoleucel (cilta-cel) chimeric antigen receptor T-cell therapy vs standard treatments for patients ...
A fixed duration combination of venetoclax with acalabrutinib, with or without obinutuzumab, was superior to standard ...
There will continue to be an increase in the integration of AI in daily workflows and decision-making as AI increases in ...
Medication errors and adverse drug reactions (ADRs) are major health concerns globally, with ADRs being a leading cause of hospitalisations.
SAN DIEGO -- A fixed-duration oral combination significantly reduced the risk of disease progression or death compared with ...
Dr. Cudkowicz is the Chair of Neurology at MGH, Director of the Sean M. Healey & AMG Center for ALS, and is the Julieanne Dorn Professor of Neurology at Harvard Medical School. A member of the ...
GeNeuro (Euronext Paris: CH0308403085 - GNRO), a biopharmaceutical company focused on addressing the factors driving the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback